Integrated DeepTech
Healthcare Group

Turning scientific innovation into scalable business

Proven Track Record

Steady growth in revenue, EBITDA, and strategic partnerships. Solid reputation and tangible results.

Dual growth model

Stable organic expansion and Deep Tech innovation: recurring revenues and new patented technologies

Research Ecosystem in Trieste

The Trieste Research ecosystem has a researcher density four times higher than the EU/USA.

IPO Target 2026 on Euronest Growth Paris

Upcoming listing on Euronext Growth Paris: Fundraising for international scale-up

Biovalley Investments Partner (BIP)is a pharmaceutical company, innovative SME, and integrated industrial group that is revolutionizing the healthcare sector by combining the solidity of subsidiaries SMEs with the disruptive power of high-potential Deep Tech Innovation.

Founded in 2016 and recognized as an Innovative SME, BIP operates through two complementary Business Units: BioTech & Pharma and BioICT.: BioTech & Pharma e BioICT.

BIP’s strategy consists of identifying revolutionary technologies and scientific discoveries, integrating them into the group’s SMEs, and quickly bringing them to market in the healthcare sector.